Walgreens Boots Alliance Inc (WBA) Expected to Post Earnings of $1.49 Per Share

Equities analysts forecast that Walgreens Boots Alliance Inc (NASDAQ:WBA) will post earnings of $1.49 per share for the current fiscal quarter, according to Zacks. Ten analysts have provided estimates for Walgreens Boots Alliance’s earnings. The highest EPS estimate is $1.58 and the lowest is $1.43. Walgreens Boots Alliance reported earnings per share of $1.33 during the same quarter last year, which would suggest a positive year-over-year growth rate of 12%. The business is scheduled to announce its next earnings report on Thursday, July 5th.

On average, analysts expect that Walgreens Boots Alliance will report full-year earnings of $5.91 per share for the current year, with EPS estimates ranging from $5.58 to $6.00. For the next year, analysts expect that the company will report earnings of $6.49 per share, with EPS estimates ranging from $6.08 to $6.74. Zacks Investment Research’s EPS averages are a mean average based on a survey of sell-side analysts that follow Walgreens Boots Alliance.

How to Become a New Pot Stock Millionaire

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Wednesday, March 28th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.18. The firm had revenue of $33.02 billion during the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a net margin of 3.33% and a return on equity of 20.38%. The business’s revenue was up 12.1% on a year-over-year basis. During the same period last year, the company earned $1.36 earnings per share.

A number of brokerages have recently issued reports on WBA. BidaskClub cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, April 10th. Zacks Investment Research upgraded shares of Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $71.00 price objective for the company in a report on Saturday, April 7th. Jefferies Group set a $85.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, April 3rd. Scotiabank reduced their price objective on shares of Walgreens Boots Alliance from $93.00 to $91.00 and set an “outperform” rating for the company in a report on Monday, April 2nd. Finally, Pivotal Research set a $70.00 price objective on shares of Walgreens Boots Alliance and gave the company a “hold” rating in a report on Thursday, March 29th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $83.20.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Nordea Investment Management AB raised its position in shares of Walgreens Boots Alliance by 1.0% in the third quarter. Nordea Investment Management AB now owns 10,182,388 shares of the pharmacy operator’s stock valued at $786,284,000 after purchasing an additional 96,552 shares during the period. Caisse DE Depot ET Placement DU Quebec raised its position in shares of Walgreens Boots Alliance by 11.0% in the fourth quarter. Caisse DE Depot ET Placement DU Quebec now owns 7,547,745 shares of the pharmacy operator’s stock valued at $548,117,000 after purchasing an additional 748,442 shares during the period. CI Global Investments Inc. raised its position in shares of Walgreens Boots Alliance by 32.0% in the fourth quarter. CI Global Investments Inc. now owns 7,373,589 shares of the pharmacy operator’s stock valued at $535,470,000 after purchasing an additional 1,785,449 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Walgreens Boots Alliance by 12.5% in the third quarter. Dimensional Fund Advisors LP now owns 6,641,826 shares of the pharmacy operator’s stock valued at $512,893,000 after purchasing an additional 735,917 shares during the period. Finally, Wells Fargo & Company MN raised its position in shares of Walgreens Boots Alliance by 9.9% in the fourth quarter. Wells Fargo & Company MN now owns 6,533,542 shares of the pharmacy operator’s stock valued at $474,466,000 after purchasing an additional 586,784 shares during the period. 60.90% of the stock is currently owned by institutional investors.

Shares of NASDAQ WBA traded down $1.22 during mid-day trading on Friday, reaching $65.04. 1,589,607 shares of the company’s stock traded hands, compared to its average volume of 5,833,745. The stock has a market capitalization of $65,420.18, a P/E ratio of 12.75, a P/E/G ratio of 1.07 and a beta of 1.16. Walgreens Boots Alliance has a 1-year low of $61.74 and a 1-year high of $87.79. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.90 and a quick ratio of 0.45.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 12th. Shareholders of record on Friday, May 18th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.46%. The ex-dividend date is Thursday, May 17th. Walgreens Boots Alliance’s dividend payout ratio is 31.37%.

ILLEGAL ACTIVITY WARNING: This article was originally reported by Week Herald and is the sole property of of Week Herald. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international copyright & trademark legislation. The original version of this article can be viewed at https://weekherald.com/2018/04/19/walgreens-boots-alliance-inc-wba-expected-to-post-earnings-of-1-49-per-share.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply